Sign in
4

Changes in Ownership

Mentari Therapeutics, Inc. Filed Acc 0001213900-22-080992

Options or other derivatives

  • Sr VP & General Manager acquired 4,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Johnson Shane Aaron · Sr VP & General Manager

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-16 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +4,200 8,000 D
Loading xslF345X03/ownership.xml…